Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching

OBJECTIVES: Clinical studies on immune checkpoint inhibitors (ICIs) combined with neoadjuvant chemotherapy (nCT) have been carried out for the resectable esophageal squamous cell carcinoma (ESCC). So far, few studies have compared the survival outcomes of nCT plus ICIs and nCT alone. This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Shao-Wu, Zhai, Chang, Zhang, Wei, He, Ming, Liu, Qing-Yi, Yao, Ji-Fang, Wang, Rui, Tian, Zi-Qiang, Wang, Jun, Liu, Jun-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585292/
https://www.ncbi.nlm.nih.gov/pubmed/36275724
http://dx.doi.org/10.3389/fimmu.2022.970534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585292/
https://www.ncbi.nlm.nih.gov/pubmed/36275724
http://dx.doi.org/10.3389/fimmu.2022.970534

Ejemplares similares